Regulators Suggest Restricted Use of Drug
British regulators recommended that physicians restrict the use of the anti-depressant Efexor because its use could have side effects for heart health and pose other risks that require more careful monitoring than its competitors. The drug’s manufacturer, Wyeth, said it would challenge the decision, but its shares slipped 3 percent.
Dr. John Grohol is the CEO and founder of Psych Central. He is an author, researcher and expert in mental health online, and has been writing about online behavior, mental health and psychology issues -- as well as the intersection of technology and human behavior -- since 1992. Dr. Grohol sits on the editorial board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory Medicine.Like this author?
Catch up on other posts by John M. Grohol, PsyD (or subscribe to their feed).
Comments
This post currently has one comment. You can read the comments or leave your own thoughts on our new comments page.
Trackbacks
No trackbacks yet to this post.
Last reviewed: By John M. Grohol, Psy.D. on 7 Dec 2004
Published on PsychCentral.com. All rights reserved.
APA Reference
Grohol, J. (2004). Regulators Suggest Restricted Use of Drug. Psych Central. Retrieved on May 25, 2012, from http://psychcentral.com/blog/archives/2004/12/07/regulators-suggest-restricted-use-of-drug/
Grohol, J. (2004). Regulators Suggest Restricted Use of Drug. Psych Central. Retrieved on May 25, 2012, from http://psychcentral.com/blog/archives/2004/12/07/regulators-suggest-restricted-use-of-drug/
